INNOVATING WITH CANNABIS: 5 KEY TAKEAWAYS FROM CANNABIS EUROPA

INNOVATING WITH CANNABIS: 5 KEY TAKEAWAYS FROM CANNABIS EUROPA

Industry trends in Europe are heading towards a research-driven approach to cannabis and the further assertion of the drug as a medicine and a way to help people that are suffering. Kfir Kachlon, Senior Analyst and Cannabis-Tech Lead at OurCrowd writes on his experience at Cannabis Europa.  This past May at Cannabis Europa, Europe’s largest cannabis convention, I was invited to participate on a panel about Investment in the European Medical Cannabis Industry. This year’s Cannabis Europa was an incredible experience to be a part of with a crowd of more than 400 people gathered to discuss the future of...

GET THE MOST OUT OF CANNABIS EUROPA

GET THE MOST OUT OF CANNABIS EUROPA

Be curious Cannabis Europa is all about facilitating new ideas and helping you learn all you want to know about medical cannabis in Europe. No one is an expert in all areas of medical cannabis, but absorbing new knowledge about areas that you may be less familiar with can only be of benefit moving forward. So sit in on the emerging science panel and have your mind blown by the latest cannabinoid research. Become an expert on European implementation issues listening to Ian Dunt in conversation with representative from the European Parliament and European Medicines Agency. Learn how to create...

COULD CANNABIS EUROPA BE THE TURNING POINT IN THE UK?

COULD CANNABIS EUROPA BE THE TURNING POINT IN THE UK?

Alfie Dingley, Victoria Atkins, the Royal College of Nursing… More and more stories are making headlines relating to medical cannabis in the United Kingdom. They reflect both the growing interest in medical cannabis and what many view as its imminent regulation. To top all that, Cannabis Europa, the largest conference about medical cannabis in Europe, will take place in London on Tuesday 22nd May. Right now, everybody is waiting for the Home Office’s response on whether or not they’ll grant Alfie Dingley a license to import medical cannabis from the Netherlands. On the other hand, we’re in the absurd situation where the...

THE ECONOMICS OF CANNABIS LEGALISATION

THE ECONOMICS OF CANNABIS LEGALISATION

Speculation about the economic impact of legalisation is running rampant as medical cannabis markets open across the globe and Canada prepares for the introduction of a legal, commercial marketplace for recreational cannabis. Dan Rowland of 420 Advisory Management writes about the economic gains of legal cannabis models. Governments, businesses and economic development organisations alike are told to open the floodgates, because the rivers of cash that legalisation brings will be flowing toward them any day now. While there is no question that cannabis-related revenue can be a boost to local economies and governments, a little context and tempered expectations should...

UK MUST KEEP PACE WITH EUROPE, SAY POLITICAL AND INDUSTRY LEADERS

UK MUST KEEP PACE WITH EUROPE, SAY POLITICAL AND INDUSTRY LEADERS

London’s Hanway Associates to host Cannabis Europa, a major conference examining the state of Medical Cannabis in Europe  North American investors eyeing up European market as attitudes towards medical cannabis change Experts around the world gather at The Barbican in London on 22nd May, for Cannabis Europa to discuss future of medical cannabis in the UK Speakers include Members of UK Parliament, Members of European Parliament, business leaders, academics, scientists, and medicine regulators The conference will focus on the rapid pace of the industry’s evolution in a complex, diverse continent with a vast number of potential patients Cannabis Europa is...

KEEPING PATIENTS AT THE HEART OF POLICY

KEEPING PATIENTS AT THE HEART OF POLICY

A crucial part of any medical cannabis programme is the patients. They often play a key role in convincing governments to implement such programmes through their advocacy, and their needs and concerns are of utmost importance when it comes to deciding what kind of programme to put in place. Delegates at Cannabis Europa will have the opportunity to hear from influential medical cannabis patients from across the British Isles, Europe, and beyond. These include Clark French, Multiple Sclerosis sufferer and founder of the United Patients Alliance in the UK, who will be chairing our Patient Stories Panel.  (Clark French, Source:...

PROMISES AND PITFALLS : MEDICAL CANNABIS AND PUBLIC HEALTH

PROMISES AND PITFALLS : MEDICAL CANNABIS AND PUBLIC HEALTH

One of the key challenges facing regulators and producers in implementing medical cannabis programmes in any jurisdiction is how to do so in a way that best promotes and protects public health.  Medical cannabis programmes come with their own unique set of public health issues to consider, more so, perhaps, than regulated recreational cannabis models. Potential pitfalls are abundant. There is, for example, the decades-old debate over whether medical cannabis should be available in a smokable form (as it is in many US States including California and Colorado) or whether it might be better to require patients to vaporise, eat, or...

CANNABIS TRENDS: WHAT DO THEY MEAN FOR EUROPE?

CANNABIS TRENDS: WHAT DO THEY MEAN FOR EUROPE?

European medical cannabis markets are not yet mature, and consumer trends are only beginning to emerge as product choice broadens. What can be learnt from the more mature markets that have been operating the other side of the Atlantic?   Roy Bingham, CEO and Co-founder of BDS Analytics weighs in. In North America, legal cannabis retail sales in 2017 were $9.2 billion. We project that they will grow to over $24 Billion by 2021. We are confident on our predictions for that growth because, despite US Federal prohibition, state laws have been passed that already pave the way. Cannabis is North...

  • 1
  • 4
  • 5